Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

In this study of patients with hepatitis C virus infection residing in rural areas or prisons in New Mexico, treatment by primary care physicians (PCPs) trained and supported by university specialists through videoconferencing resulted in high rates of sustained virologic response. The Extension for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2011-06, Vol.364 (23), p.2199-2207
Hauptverfasser: Arora, Sanjeev, Thornton, Karla, Murata, Glen, Deming, Paulina, Kalishman, Summers, Dion, Denise, Parish, Brooke, Burke, Thomas, Pak, Wesley, Dunkelberg, Jeffrey, Kistin, Martin, Brown, John, Jenkusky, Steven, Komaromy, Miriam, Qualls, Clifford
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2207
container_issue 23
container_start_page 2199
container_title The New England journal of medicine
container_volume 364
creator Arora, Sanjeev
Thornton, Karla
Murata, Glen
Deming, Paulina
Kalishman, Summers
Dion, Denise
Parish, Brooke
Burke, Thomas
Pak, Wesley
Dunkelberg, Jeffrey
Kistin, Martin
Brown, John
Jenkusky, Steven
Komaromy, Miriam
Qualls, Clifford
description In this study of patients with hepatitis C virus infection residing in rural areas or prisons in New Mexico, treatment by primary care physicians (PCPs) trained and supported by university specialists through videoconferencing resulted in high rates of sustained virologic response. The Extension for Community Healthcare Outcomes (ECHO) model was developed by the University of New Mexico (UNM) Health Sciences Center as a platform for both delivery of services and outcomes research. 1 , 2 The objectives of the ECHO program are to improve the access of minorities and other underserved populations to best-practice care for hepatitis C virus (HCV) infection, to determine the safety and efficacy of treatment for HCV infection based on the ECHO model in rural communities, and to compare the effectiveness of the ECHO model with that of university-based clinic treatment. The ECHO program increases the accessibility of populations . . .
doi_str_mv 10.1056/NEJMoa1009370
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_871379356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>871379356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-6ba8265a43e4ec797b48d6634420da7acb77eb790f4328b1d09b204f46e5c0223</originalsourceid><addsrcrecordid>eNp10ElLxDAUB_Agio7L0asEQTxVs7wm7VHKqCPqeBi9ljR9hQ7TZkxaYb69lRlXMJdH4Mdb_oQcc3bBWawuH8d3D85wxlKp2RYZ8VjKCICpbTJiTCQR6FTukf0Q5mx4HNJdsie4klxyNSLTad9Z12CgrqIzj6ZrsO1o5Ty9xaXp6q4ONKMvte8DnbQV2q52LS1W9MnXjfErmhmPw8e91SX6cEh2KrMIeLSpB-T5ejzLbqP76c0ku7qPLCTQRaowiVCxAYmAVqe6gKRUSgIIVhptbKE1FjplFUiRFLxkaSEYVKAwtkwIeUDO132X3r32GLq8qYPFxcK06PqQJ5rL4fBYDfL0j5y73rfDch-IJwBcDyhaI-tdCB6rfLk-L-cs_8g5_5Xz4E82TfuiwfJLfwY7gLMNMMGaReVNa-vw7UDIJGY_XNOEvMV588_AdyLijs8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>871184417</pqid></control><display><type>article</type><title>Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Arora, Sanjeev ; Thornton, Karla ; Murata, Glen ; Deming, Paulina ; Kalishman, Summers ; Dion, Denise ; Parish, Brooke ; Burke, Thomas ; Pak, Wesley ; Dunkelberg, Jeffrey ; Kistin, Martin ; Brown, John ; Jenkusky, Steven ; Komaromy, Miriam ; Qualls, Clifford</creator><creatorcontrib>Arora, Sanjeev ; Thornton, Karla ; Murata, Glen ; Deming, Paulina ; Kalishman, Summers ; Dion, Denise ; Parish, Brooke ; Burke, Thomas ; Pak, Wesley ; Dunkelberg, Jeffrey ; Kistin, Martin ; Brown, John ; Jenkusky, Steven ; Komaromy, Miriam ; Qualls, Clifford</creatorcontrib><description>In this study of patients with hepatitis C virus infection residing in rural areas or prisons in New Mexico, treatment by primary care physicians (PCPs) trained and supported by university specialists through videoconferencing resulted in high rates of sustained virologic response. The Extension for Community Healthcare Outcomes (ECHO) model was developed by the University of New Mexico (UNM) Health Sciences Center as a platform for both delivery of services and outcomes research. 1 , 2 The objectives of the ECHO program are to improve the access of minorities and other underserved populations to best-practice care for hepatitis C virus (HCV) infection, to determine the safety and efficacy of treatment for HCV infection based on the ECHO model in rural communities, and to compare the effectiveness of the ECHO model with that of university-based clinic treatment. The ECHO program increases the accessibility of populations . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa1009370</identifier><identifier>PMID: 21631316</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Waltham, MA: Massachusetts Medical Society</publisher><subject>Academic Medical Centers ; Adult ; Analysis of Variance ; Antiviral Agents - therapeutic use ; Biological and medical sciences ; Chronic infection ; Clinics ; Community Health Services ; Female ; General aspects ; Genotype &amp; phenotype ; Genotypes ; Health facilities ; Health sciences ; Health Services Accessibility ; Hepacivirus - drug effects ; Hepacivirus - genetics ; Hepatitis ; Hepatitis C ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - therapy ; Hepatitis C, Chronic - virology ; Human viral diseases ; Humans ; Infections ; Infectious diseases ; Interdisciplinary aspects ; Interferon-alpha - therapeutic use ; Laboratories ; Liver cancer ; Male ; Medical sciences ; Medically Underserved Area ; Middle Aged ; Minority &amp; ethnic groups ; New Mexico ; Patients ; Physicians, Primary Care ; Polyethylene Glycols - therapeutic use ; Primary care ; Prisoners ; Prisons ; Prospective Studies ; Recombinant Proteins ; Rural areas ; Rural Health Services ; Telemedicine ; Treatment Outcome ; Urban areas ; Videoconferencing ; Viral diseases ; Viral hepatitis</subject><ispartof>The New England journal of medicine, 2011-06, Vol.364 (23), p.2199-2207</ispartof><rights>Copyright © 2011 Massachusetts Medical Society. All rights reserved.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-6ba8265a43e4ec797b48d6634420da7acb77eb790f4328b1d09b204f46e5c0223</citedby><cites>FETCH-LOGICAL-c484t-6ba8265a43e4ec797b48d6634420da7acb77eb790f4328b1d09b204f46e5c0223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa1009370$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/871184417?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2757,2758,26102,27923,27924,52381,54063,64384,64386,64388,72240</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24238506$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21631316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arora, Sanjeev</creatorcontrib><creatorcontrib>Thornton, Karla</creatorcontrib><creatorcontrib>Murata, Glen</creatorcontrib><creatorcontrib>Deming, Paulina</creatorcontrib><creatorcontrib>Kalishman, Summers</creatorcontrib><creatorcontrib>Dion, Denise</creatorcontrib><creatorcontrib>Parish, Brooke</creatorcontrib><creatorcontrib>Burke, Thomas</creatorcontrib><creatorcontrib>Pak, Wesley</creatorcontrib><creatorcontrib>Dunkelberg, Jeffrey</creatorcontrib><creatorcontrib>Kistin, Martin</creatorcontrib><creatorcontrib>Brown, John</creatorcontrib><creatorcontrib>Jenkusky, Steven</creatorcontrib><creatorcontrib>Komaromy, Miriam</creatorcontrib><creatorcontrib>Qualls, Clifford</creatorcontrib><title>Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>In this study of patients with hepatitis C virus infection residing in rural areas or prisons in New Mexico, treatment by primary care physicians (PCPs) trained and supported by university specialists through videoconferencing resulted in high rates of sustained virologic response. The Extension for Community Healthcare Outcomes (ECHO) model was developed by the University of New Mexico (UNM) Health Sciences Center as a platform for both delivery of services and outcomes research. 1 , 2 The objectives of the ECHO program are to improve the access of minorities and other underserved populations to best-practice care for hepatitis C virus (HCV) infection, to determine the safety and efficacy of treatment for HCV infection based on the ECHO model in rural communities, and to compare the effectiveness of the ECHO model with that of university-based clinic treatment. The ECHO program increases the accessibility of populations . . .</description><subject>Academic Medical Centers</subject><subject>Adult</subject><subject>Analysis of Variance</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chronic infection</subject><subject>Clinics</subject><subject>Community Health Services</subject><subject>Female</subject><subject>General aspects</subject><subject>Genotype &amp; phenotype</subject><subject>Genotypes</subject><subject>Health facilities</subject><subject>Health sciences</subject><subject>Health Services Accessibility</subject><subject>Hepacivirus - drug effects</subject><subject>Hepacivirus - genetics</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - therapy</subject><subject>Hepatitis C, Chronic - virology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Interdisciplinary aspects</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Laboratories</subject><subject>Liver cancer</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medically Underserved Area</subject><subject>Middle Aged</subject><subject>Minority &amp; ethnic groups</subject><subject>New Mexico</subject><subject>Patients</subject><subject>Physicians, Primary Care</subject><subject>Polyethylene Glycols - therapeutic use</subject><subject>Primary care</subject><subject>Prisoners</subject><subject>Prisons</subject><subject>Prospective Studies</subject><subject>Recombinant Proteins</subject><subject>Rural areas</subject><subject>Rural Health Services</subject><subject>Telemedicine</subject><subject>Treatment Outcome</subject><subject>Urban areas</subject><subject>Videoconferencing</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10ElLxDAUB_Agio7L0asEQTxVs7wm7VHKqCPqeBi9ljR9hQ7TZkxaYb69lRlXMJdH4Mdb_oQcc3bBWawuH8d3D85wxlKp2RYZ8VjKCICpbTJiTCQR6FTukf0Q5mx4HNJdsie4klxyNSLTad9Z12CgrqIzj6ZrsO1o5Ty9xaXp6q4ONKMvte8DnbQV2q52LS1W9MnXjfErmhmPw8e91SX6cEh2KrMIeLSpB-T5ejzLbqP76c0ku7qPLCTQRaowiVCxAYmAVqe6gKRUSgIIVhptbKE1FjplFUiRFLxkaSEYVKAwtkwIeUDO132X3r32GLq8qYPFxcK06PqQJ5rL4fBYDfL0j5y73rfDch-IJwBcDyhaI-tdCB6rfLk-L-cs_8g5_5Xz4E82TfuiwfJLfwY7gLMNMMGaReVNa-vw7UDIJGY_XNOEvMV588_AdyLijs8</recordid><startdate>20110609</startdate><enddate>20110609</enddate><creator>Arora, Sanjeev</creator><creator>Thornton, Karla</creator><creator>Murata, Glen</creator><creator>Deming, Paulina</creator><creator>Kalishman, Summers</creator><creator>Dion, Denise</creator><creator>Parish, Brooke</creator><creator>Burke, Thomas</creator><creator>Pak, Wesley</creator><creator>Dunkelberg, Jeffrey</creator><creator>Kistin, Martin</creator><creator>Brown, John</creator><creator>Jenkusky, Steven</creator><creator>Komaromy, Miriam</creator><creator>Qualls, Clifford</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20110609</creationdate><title>Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers</title><author>Arora, Sanjeev ; Thornton, Karla ; Murata, Glen ; Deming, Paulina ; Kalishman, Summers ; Dion, Denise ; Parish, Brooke ; Burke, Thomas ; Pak, Wesley ; Dunkelberg, Jeffrey ; Kistin, Martin ; Brown, John ; Jenkusky, Steven ; Komaromy, Miriam ; Qualls, Clifford</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-6ba8265a43e4ec797b48d6634420da7acb77eb790f4328b1d09b204f46e5c0223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Academic Medical Centers</topic><topic>Adult</topic><topic>Analysis of Variance</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chronic infection</topic><topic>Clinics</topic><topic>Community Health Services</topic><topic>Female</topic><topic>General aspects</topic><topic>Genotype &amp; phenotype</topic><topic>Genotypes</topic><topic>Health facilities</topic><topic>Health sciences</topic><topic>Health Services Accessibility</topic><topic>Hepacivirus - drug effects</topic><topic>Hepacivirus - genetics</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - therapy</topic><topic>Hepatitis C, Chronic - virology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Interdisciplinary aspects</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Laboratories</topic><topic>Liver cancer</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medically Underserved Area</topic><topic>Middle Aged</topic><topic>Minority &amp; ethnic groups</topic><topic>New Mexico</topic><topic>Patients</topic><topic>Physicians, Primary Care</topic><topic>Polyethylene Glycols - therapeutic use</topic><topic>Primary care</topic><topic>Prisoners</topic><topic>Prisons</topic><topic>Prospective Studies</topic><topic>Recombinant Proteins</topic><topic>Rural areas</topic><topic>Rural Health Services</topic><topic>Telemedicine</topic><topic>Treatment Outcome</topic><topic>Urban areas</topic><topic>Videoconferencing</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arora, Sanjeev</creatorcontrib><creatorcontrib>Thornton, Karla</creatorcontrib><creatorcontrib>Murata, Glen</creatorcontrib><creatorcontrib>Deming, Paulina</creatorcontrib><creatorcontrib>Kalishman, Summers</creatorcontrib><creatorcontrib>Dion, Denise</creatorcontrib><creatorcontrib>Parish, Brooke</creatorcontrib><creatorcontrib>Burke, Thomas</creatorcontrib><creatorcontrib>Pak, Wesley</creatorcontrib><creatorcontrib>Dunkelberg, Jeffrey</creatorcontrib><creatorcontrib>Kistin, Martin</creatorcontrib><creatorcontrib>Brown, John</creatorcontrib><creatorcontrib>Jenkusky, Steven</creatorcontrib><creatorcontrib>Komaromy, Miriam</creatorcontrib><creatorcontrib>Qualls, Clifford</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arora, Sanjeev</au><au>Thornton, Karla</au><au>Murata, Glen</au><au>Deming, Paulina</au><au>Kalishman, Summers</au><au>Dion, Denise</au><au>Parish, Brooke</au><au>Burke, Thomas</au><au>Pak, Wesley</au><au>Dunkelberg, Jeffrey</au><au>Kistin, Martin</au><au>Brown, John</au><au>Jenkusky, Steven</au><au>Komaromy, Miriam</au><au>Qualls, Clifford</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2011-06-09</date><risdate>2011</risdate><volume>364</volume><issue>23</issue><spage>2199</spage><epage>2207</epage><pages>2199-2207</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>In this study of patients with hepatitis C virus infection residing in rural areas or prisons in New Mexico, treatment by primary care physicians (PCPs) trained and supported by university specialists through videoconferencing resulted in high rates of sustained virologic response. The Extension for Community Healthcare Outcomes (ECHO) model was developed by the University of New Mexico (UNM) Health Sciences Center as a platform for both delivery of services and outcomes research. 1 , 2 The objectives of the ECHO program are to improve the access of minorities and other underserved populations to best-practice care for hepatitis C virus (HCV) infection, to determine the safety and efficacy of treatment for HCV infection based on the ECHO model in rural communities, and to compare the effectiveness of the ECHO model with that of university-based clinic treatment. The ECHO program increases the accessibility of populations . . .</abstract><cop>Waltham, MA</cop><pub>Massachusetts Medical Society</pub><pmid>21631316</pmid><doi>10.1056/NEJMoa1009370</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2011-06, Vol.364 (23), p.2199-2207
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_871379356
source MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Academic Medical Centers
Adult
Analysis of Variance
Antiviral Agents - therapeutic use
Biological and medical sciences
Chronic infection
Clinics
Community Health Services
Female
General aspects
Genotype & phenotype
Genotypes
Health facilities
Health sciences
Health Services Accessibility
Hepacivirus - drug effects
Hepacivirus - genetics
Hepatitis
Hepatitis C
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - therapy
Hepatitis C, Chronic - virology
Human viral diseases
Humans
Infections
Infectious diseases
Interdisciplinary aspects
Interferon-alpha - therapeutic use
Laboratories
Liver cancer
Male
Medical sciences
Medically Underserved Area
Middle Aged
Minority & ethnic groups
New Mexico
Patients
Physicians, Primary Care
Polyethylene Glycols - therapeutic use
Primary care
Prisoners
Prisons
Prospective Studies
Recombinant Proteins
Rural areas
Rural Health Services
Telemedicine
Treatment Outcome
Urban areas
Videoconferencing
Viral diseases
Viral hepatitis
title Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A24%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20Treatment%20for%20Hepatitis%20C%20Virus%20Infection%20by%20Primary%20Care%20Providers&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Arora,%20Sanjeev&rft.date=2011-06-09&rft.volume=364&rft.issue=23&rft.spage=2199&rft.epage=2207&rft.pages=2199-2207&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJMoa1009370&rft_dat=%3Cproquest_cross%3E871379356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=871184417&rft_id=info:pmid/21631316&rfr_iscdi=true